157
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Where are the medical countermeasures against the ARS and DEARE? A current topic relative to an animal model research platform, radiation exposure context, the acute and delayed effects of acute exposure, and the FDA animal rule

Pages 994-1008 | Received 03 Dec 2022, Accepted 04 Feb 2023, Published online: 15 Mar 2023

References

  • Accardi MV, Donini O, Rumage A, Ascah A, Haruna J, Pouliot M, Bujold K, Huang H, Wierzbicki W, Stamatopoulos J, et al. 2020. Characterization of a partial-body irradiation model with oral cavity shielding in nonhuman primates. Int J Radiat Biol. 96(1):100–111.
  • Ainsworth EJ, Leong GF, Kendall K, Alpen EL. 1965. Comparative lethality responses of neutron and x-irradiated dogs: influence of dose rate and exposure aspect. Radiat Res. 26(1):32–43.
  • Alpen EL. 1991. Supplement: the international colloquium on neutron radiation biology. The historical background for large-animal studies with neutrons of various energies. Radiat Res. 128(1):S37–S41.
  • Alpen EL, Sheline GE. 1954. The combined effects of thermal burns and whole-body X irradiation on survival time and mortality. Ann Surg. 140(1):113–118.
  • Allen RG, Brown FA, Logie LC, Rovner DR, Wilson J, Zellmer RW. 1960. Acute effects of gamma radiation in the primate. Radiat Res. 12(5):532–559.
  • Allen JR, Van Lancker JL, Wolf RC. 1966. Pathologic alterations produced by total body X-irradiation in monkeys. Amer J Path. 48:317–331.
  • Anno GH, Baum SJ, Withers HR, Young RW. 1989. Symptomatology of acute radiation effects in humans after exposure to doses of 0.5–30 Gy. Health Phys. 56:821–838.
  • Anno GH, Young RW, Bloom RM, Mercier JR. 2003. Dose response relationships for acute ionizing-radiation lethality. Health Phys. 84(5):565–575.
  • Antonic V, Jackson IL, Ganga G, Shea-Donohue T, Zeljko Vujaskovic Z. 2017. Development of A Novel Murine Model of combined radiation and peripheral tissue trauma injuries. Radiat Res. 187(2):241–250.
  • Baker JE, Fish BL, Su J, Haworth ST, Strande JL, Komorowski RA, Migrino RQ, Doppalapudi A, Harmann L, Li XA, et al. 2009. 10 Gy total-body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. Int J Radiat Biol. 85(12):1089–1100.
  • Baranov AE, Guskova AK. 1990. Acute radiation disease in Chernobyl accident victims. In: Ricks RC, Frys SA, eds. The medical basis for radiation accident preparedness II; clinical experience and follow-up since 1979. New York: Elsevier; p. 79–87.
  • Baranov AE, Selidovkin GD, Butturini A, Gale RP. 1994. Hematopoietic recovery after 10-Gy acute total body radiation. Blood. 83:596–599.
  • Barcellos-Hoff MH. 2010. A systems biology approach to radiation biology; [accessed 2010 Aug 10] https://three.jsc.nasa.gov/articles/Barcellos-HoffSystemsBiol.pdf.
  • Becker RA, Ankley GT, Edwards SW, Kennedy SW, Linkov I, Meek B, Sachana M, Segner H, Van Der Burg B, Villeneuve DL, et al. 2015. Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence. Regul Toxicol Pharmacol. 72(3):514–537.
  • Bertho JM, Frick J, Prat M, Demarquay C, Dudoignon N, Trompier F, Gorin C, Thierry D, Gourmelon P. 2005b. Comparison of autologous cell therapy and granulocyte colony-stimulating factor (G-CSF) Injection vs G-CSF alone for the treatment of acute radiation syndrome in a nonhuman primate model. Int J Radiat Oncol Biol Phys. 63:911–920.
  • Bertho J-M, Prat M, Frick J, Demarquay C, Gaugler M-H, Dudoignon N, Clairand I, Chapel A, Gorin N-C, Thierry D, et al. 2005a. Application of autologous hematopoietic cell therapy to a nonhuman primate model of heterogeneous high-dose irradiation. Radiat Res. 163(5):557–570.
  • Blake PP, Personal C. 2022. Health Physicist/Portfolio Manager, Nuclear Test Personnel Review (RD-NTS), defense threat reduction agency. Fort Belvoir, VA.
  • Bond VP, Cronkite EP, Sondhaus CA, Imirie G, Obertson JS, Borg DC. 1957. The influence of exposure geometry on the pattern of radiation dose delivered to large animal phantoms. Radiat Res. 6(5):554–572.
  • Bond VP, Carsten AL, Bullis J, Roth SP. 1991. Severity of organ injury as a predictor of acute mortality for disparate patterns of absorbed dose distribution. Radiat Res. 128(1 Suppl):S9–S11.
  • Booth C, Tudor G, Tonge N, Shea-Donohue T, MacVittie TJ. 2012a. Evidence of delayed gastrointestinal syndrome in high-dose irradiated mice. Health Phys. 103:400–410.
  • Booth C, Tudor G, Tudor J, Katz BP, MacVittie TJ. 2012b. Acute gastrointestinal syndrome in high-dose irradiated mice. Health Phys. 103:383–399.
  • Booth C, Tudor GL, Katz B, MacVittie TJ. 2015. The delayed effects of acute radiation syndrome: evidence of long-term functional changes in the clonogenic cells of the small intestine. Health Phys. 109(5):399–413.
  • Broerse JJ, Van Bekkum DW, Hollander CF, Davids JA. 1978. Mortality of monkeys after exposure to fission neutrons and the effect of autologous bone marrow transplantation. Int J Radiat Biol Relat Stud Phys Chem Med. 34(3):253–264.
  • Browne D, Weiss JF, Macvittie TJ, Pillai MV. 1990. Consensus summary statement on the treatment of radiation injuries. In: Browne D, Weiss JF, MacVittie TJ, Pillai MV, editors. Treatment of radiation injuries. Boston, MA: Springer.
  • Bradford GB, Williams B, Rossi R, Bertoncello I. 1997. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol. 25:445–453.
  • Brooks JW, Evans EI, Ham WT, Reid JD. 1952. The influence of external body radiation on mortality from thermal burns. Ann Surg. 136(3):533–545.
  • Brook I, Germana A, Giraldo DE, Camp-Hyde TD, Bolduc DL, Foriska MA, Elliott TB, Thakar JH, Shoemaker MO, Jackson WE, et al. 2005. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in cobalt-60-gamma-photon-irradiated and sham-irradiated mice. J Antimicrob Chemother. 56(6):1074–1080.
  • Bujold K, Hauer-Jensen M, Donini O, Rumage A, Hartman D, Hendrickson HP, Stamatopoulos J, Naraghi H, Pouliot M, Ascah A, et al. 2016. Citrulline as a biomarker for gastrointestinal-acute radiation syndrome: species differences and experimental condition effects. Radiat Res. 186(1):71–78.
  • Bunin DI, Bakke J, Green CE, Javitz HS, Fielden M, Chang PY. 2020. Romiplostim (Nplate®) as an effective radiation countermeasure to improve survival and platelet recovery in mice. Int J Radiat Biol. 96(1):145–154.
  • Byron JW, Haigh MV, Lajtha LG. 1964. Effect of an antibiotic regime on monkeys exposed to total-body irradiation. Nature. 202:977–979.
  • Carter CL, Jones JW, Barrow K, Kieta K, Taylor-Howell C, Kearney S, Smith CP, Gibbs A, Farese AM, MacVittie TJ, et al. 2015. A MALDI-MSI approach to the characterization of radiation-induced lung injury and medical countermeasure development. Health Phys. 109(5):466–478.
  • Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, Demarquay C, Cuvelier F, Mathieu E, Trompier F, et al. 2003. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med. 5(12):1028–1038.
  • Chauhan V, Stricklin D, Cool D. 2021. The integration of the adverse outcome pathway framework to radiation risk assessment. Int J Radiat Biol. 97(1):60–67.
  • Chauhan V, Beaton D, Hamada N, Wilkins R, Burtt J, Leblanc J, Cool D, Garnier-Laplace J, Laurier D, Le Y, et al. 2022. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research. Int J Radiat Biol. 98(12):1694–1703.
  • Chauhan V, Azimzadeh O, Salomaa S, Nobuyaki H. 2022. Introduction to the special issue on adverse outcome pathways in radiation protection. Editorial Int J Radiat Biol. 98(12):92–93.
  • Chua HL, Plett PA, Sampson CH, Joshi M, Tabbey R, Katz BP, MacVittie TJ, Orschell CM. 2012. Long-term hematopoietic stem cell damage in a murine model of the hematopoietic syndrome of the acute radiation syndrome. Health Phys. 103(4):356–366.
  • Chua HL, Plett PA, Sampson CH, Katz BP, Carnathan GW, MacVittie TJ, Lenden K, Orschell CM. 2014. Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors. Health Phys. 106(1):21–38.
  • Chua HL, Plett PA, Fisher A, Sampson CH, Vemula S, Feng H, Sellamuthu R, Wu T, MacVittie TJ, Orschell CM. 2019. Lifelong residual bone marrow damage in murine survivors of the hematopoietic acute radiation syndrome (H-ARS): a compilation of studies comprising the Indiana University experience. Health Phys. 116(4):546–557.
  • Cline JM, Dugan G, Bourland JD, Perry DL, Stitzel JD, Weaver AA, Jiang C, Tovmasyan A, Owzar K, Spasojevic I, et al. 2018. Post-irradiation treatment with a superoxide dismutase mimic, MnTnHex-2-PyP(5+), mitigates radiation injury in the lungs of non-human primates after whole-thorax exposure to ionizing radiation. Antioxidants. 7:340.
  • Cohen EP, Hankey KG, Bennett AW, Farese AM, Parker GA, MacVittie TJ. 2017. Acute and chronic kidney injury in a non-human primate model of partial-body irradiation with bone marrow sparing. Radiat Res. 188:661–671.
  • Cohen EP, Hankey KG, Farese AM, Parker GA, Jones J, Kane MA, Bennett A, MacVittie TJ. 2019. Radiation nephropathy in a nonhuman primate model of partial-body irradiation with minimal bone marrow sparing. Part 1: acute and chronic kidney injury and the influence of Neupogen. Health Phys. 116(3):401–408.
  • Conklin JJ, Walker Ri MT. 1985. First International Symposium, pathophysiology of combined injury and trauma: an overview, pp. 20–35. In: Walker RI, Gruber DF, MacVittie TJ, Conklin JJ. editors. The pathophysiology of combined injury and trauma. Baltimore, MD: University Park Press. p. 3–10.
  • Cui W, Bennett AW, Zhang P, Barrow KR, Kearney SR, Hankey KG, Taylor-Howell C, Gibbs AM, Smith CP, MacVittie TJ. 2016. A non-human primate model of radiation-induced cachexia. Sci Rep. 6:23612.
  • Dainiak N, Gent RN, Carr Z, Schneider R, Bader J, Buglova E, Chao N, Coleman CN, Ganser A, Gorin C, et al. 2011a. First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation. Disaster Med Public Health Prep. 5(3):202–212.
  • Dainiak N, Gent RN, Carr Z, Schneider R, Bader J, Buglova E, Chao N, Coleman CN, Ganser A, Gorin C, et al. 2011b. Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems. Disaster Med Public Health Prep. 5(3):183–201.
  • Dainiak N, Albanese J. 2022. Medical management of the acute radiation syndrome. J Radiol Prot. 42(3):031002.
  • Dalrymple GV, Lindsay IR, Ghidoni JJ. 1965. The effect of 2-MeV whole-body x-radiation on primates. Radiat Res. 25(2):377–400.
  • de Faria EB, Barrow K, Ruehle BT, Parker JT, Swartz E, Taylor-Howell C, Kieta KM, Lees C, Sleeper MM, Dobbin T, et al. 2015. The evolving MCART multimodal imaging core: establishing a protocol for computed tomography and echocardiography in the rhesus macaque to perform longitudinal analysis of radiation-induced organ injury. Health Phys. 109(5):479–492.
  • DiCarlo AL, Hatchett RJ, Kaminski JM, Ledney GD, Pellmar TC, Okunieff P, Ramakrishnan N. 2008. Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis: report of an NIAID workshop. Radiat Res. 169(6):712–721.
  • DiCarlo AL, Ramakrishnan N, Hatchett RJ. 2010. Radiation combined injury: overview of NIAID research. Health Phys. 98(6):863–867.
  • DiCarlo AL, Horta Z, Aldrich JT, Jakubowski AA, Skinner WK, Case CM. Jr. 2019. Use of growth factors and other cytokines for treatment of injuries during a radiation public health emergency. Radiat Res. 192(1):99–120.
  • Drouet M, Mourcin F, Grenier N, Leroux V, Denis J, Mayol JF, Thullier P, Lataillade JJ, Herodin F. 2004. Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosupression: long-term follow-up of hematopoiesis. Blood. 103(3):878–885.
  • Drouet M, Delaunay C, Grenier N, Garrigou P, Mayol J-F, Hérodin F. 2008. Cytokines in combination to treat radiation-induced myelosuppression: evaluation of SCF + glycoslyated EPO + pegylated G-CSF as an emergency treatment in highly irradiated monkeys. Hematologica. 93(3):465–466.
  • Drouet M, Garrigou P, Peinnequin A, Herodin F. 2014. Short-term sonic-hedgehog gene therapy to mitigate myelosuppression in highly irradiated monkeys: hype or reality. Bone Marrow Transplant. 49(2):304–309.
  • Dörr H, Lamkowski A, Graessle DH, Bennett A, Shapiro A, Farese AM, Garofalo M, MacVittie TJ, Meineke V. 2014. Linking the human response to unplanned radiation and treatment to the nonhuman primate response to controlled radiation and treatment. Health Phys. 106(1):129–134.
  • Farese AM, Cohen MV, Katz BP, Smith CP, Jackson W, Cohen D, MacVittie TJ. 2012. A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management. Health Phys. 103(4):367–382.
  • Farese AM, Hankey KG, Cohen MV, MacVittie TJ. 2015. Lymphoid and myeloid recovery in rhesus macaques following total body x-irradiation. Health Phys. 109(5):414–426.
  • Farese AM, Bennett AW, Gibbs AM, Hankey KG, Prado K, Jackson WI, MacVittie TJ. 2019. Efficacy of Neulasta or Neupogen on H- and GI-ARS mortality and hematopoietic recovery in nonhuman primates after 10 Gy irradiation with 2.5% bone marrow sparing. Health Phys. 116(3):339–353.
  • Farese AM, Booth C, Tudor GL, Cui W, Cohen EP, Parker GA, Hankey KG, MacVittie TJ. 2021. The natural history of acute radiation-induced H-ARS and concomitant multi-organ injury in the non-human primate: the MCART experience. Health Phys. 121(4):282–303.
  • Farese AM, Drouet M, Herodin F, Bertho JM, Thrall KD, Authier S, Doyle-Eisele M, MacVittie TM. 2021. Acute radiation effects, the H-ARS in the nonhuman primate: a review and new data for the cynomolgus macaque with reference to the rhesus macaque. Health Phys. 121(4):304–330.
  • Faubel S. 2008. Pulmonary complications after acute kidney injury. Adv Chronic Kidney Dis. 15(3):284–296.
  • Faubel S, Edelstein CL. 2016. Mechanisms and mediators of lung injury after acute kidney injury. Nat Rev Nephrol. 12(1):48–60.
  • Fish BL, Gao F, Narayanan J, Bergom C, Jacobs ER, Cohen EP, Moulder JE, Orschell CM, Medhora M. 2016. Combined hydration and antibiotics with lisinopril to mitigate acute and delayed high-dose radiation injuries to multiple organs. Health Phys. 111(5):410–419.
  • Fish BL, MacVittie TJ, Szabo A, Moulder JE, Medhora M. 2020. WAG/RijCmcr rat models for injuries to multiple organs by single high dose ionizing radiation: similarities to nonhuman primates (NHP). Int J Radiat Biol. 96(1):81–92.
  • Fish BL, MacVittie TJ, Gao F, Narayanan J, Gasperetti T, Scholler D, Sheinin Y, Himburg HA, Hart B, Medhora M. 2021. Rat models of partial-body irradiation with bone marrow-sparing (leg-out PBI) designed for FDA-approval of countermeasures for mitigation of acute and delayed injuries by radiation. Health Phys. 121(4):419–433.
  • Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JAH, Wingard JR. 2011. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 52(4):e56–e93.
  • Friesecke I, Beyrer K, Wedel R, Reimers K, Fliedner TM. 2000. SEARCH: a system for evaluation and archiving of radiation accidents based on case histories. Radiat Environ Biophys. 39(3):213–217.
  • Friesecke I, Beyrer K, Fliedner TM. 2001. How to cope with radiation accidents: the medical management. Br J Radiol. 74(878):121–122.
  • Fuentes A, Hyde D, Johnson I, Haston CK. 2021. Acute radiation-induced hematopoietic depletion does not alter the onset or severity of pneumonitis in mice. Radiat Res. 196(3):297–305.
  • Furth FW, Coulter MP, Miller RW, Howland JW, Swisher SN. 1953. The treatment of acute radiation syndrome in dogs with auromycin and whole blood. J Laboratory Clinical Med. 41:918–928.
  • Gafter-Gvili A, Fraser A, Mical P, Leibovici L. 2005. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med. 142(12 Pt 1):979–995.
  • Garofalo M, Bennett A, Farese AM, Harper J, Ward A, Taylor-Howell C, Cui W, Gibbs A, Lasio G, Jackson WI, et al. 2014. The delayed pulmonary syndrome following acute high-dose irradiation: a rhesus macaque model. Health Phys. 106(1):56–72.
  • Garofalo MC, Ward AA, Farese AM, Bennett A, Taylor-Howell C, Cui W, Gibbs A, Prado KL, MacVittie TJ. 2014. A pilot study in rhesus macaques to assess the treatment efficacy of a small molecular weight catalytic metalloporphyrin antioxidant (AEOL-10150) in mitigating radiation-induced lung damage. Health Phys. 106(1):73–83.
  • Ghobadi G, van der Veen S, Bartelds B, de Boer RA, Dickinson MG, de Jong JR, Faber H, Niemantsverdriet M, Brandenburg S, Berger RFM, et al. 2012. Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys. 84(5):e639–e646.
  • Grabenstein JD, Parker JS, Berkelman RL, Cantrill SV, Carlin R, Rienzo D, Drtechen AJ, MacVittie TJ, Pavin TJ, Rose AT, et al. 2010. Where are the medical countermeasures? Protecting America’s health from CBRN threats: a report of the national biodefense science board. Biosecur Bioterror. 8(2):203–207.
  • Graessle DH, Dorr H, Bennett A, Shapiro A, Farese AM, MacVittie TJ, Meineke V. 2015. Comparing the hematopoietic syndrome time course in the NHP animal model to radiation accident cases from the database SEARCH. Health Phys. 109(5):493–501.
  • Herodin F, Roy L, Grenier N, Delaunay C, Bauge S, Vaurijoux A, Gregoire E, Martin C, Alonso A, Mayol JF, et al. 2007. Antiapoptotic cytokines in combination with pegfilgrastim soon after irradiation mitigates myelosuppression in nonhuman primates exposed to high irradiation dose. Exp Hematol. 35(8):1172–1181.
  • Hill AB. 1965. The environment and disease: association or causation? Proc R Soc Med. 58(5):295–300.
  • Hsia CCW, Ravikumar P, Ye J. 2017. Acute lung injury complicating acute kidney injury: a model of endogenous alphaKlotho deficiency and distant organ dysfunction. Bone. 100:100–109.
  • Huang W, Yu J, Liu T, Defnet AE, Zalesak S, Farese AM, MacVittie TJ, Kane MA. 2020. Proteomics of non-human primate plasma after partial-body radiation with minimal bone marrow sparing. Health Phys. 119(5):621–632.
  • Huang W, Yu J, Liu T, Defnet AE, Zalesak S, Farese AM, MacVittie TM, Kane MA. 2021. Acute proteomic changes in lung after radiation: towards identifying initiating events of delayed effects of acute radiation exposure in non-human primate after partial body irradiation with minimal bone marrow sparing. Health Phys. 121(4):384–394.
  • Hughes, WT. 2002. Use of antimicrobial agents for treatment of infection in the neutropenic immunocompromised patient. In: Ricks R, Berger ME, O'Hara FMJ, editors. The medical basis for radiation accident preparedness. The clinical care of victims. Washington, DC: The Parthenon Publishing Group. p. 117–129.
  • ICRP. 1991. 1990 recommendations of the International Commission on Radiological Protection. Ann ICRP. 21(1–3):1–201.
  • Jackson DP, Sorensen DK, Cronkite EP, Bond VP, Fliedner TM. 1959. Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia. J Clin Invest. 38(10 Pt 1-2):1689–1697.
  • Jacobs ER, Narayanan J, Fish BL, Gao F, Harmann LM, Bergom C, Gasperetti T, Strande JL, Medhora M. 2019. Cardiac remodeling and reversible pulmonary hypertension during pneumonitis in rats after 13-Gy partial-body irradiation with minimal bone marrow sparing: effect of lisinopril. Health Phys. 116(4):558–565.
  • Jones JW, Bennett A, Carter CL, Tudor G, Hankey KG, Farese AM, Booth C, MacVittie TJ, Kane MA. 2015. Citrulline as a Biomarker in the non-human primate total- and partial-body irradiation models: correlation of circulating citrulline to acute and prolonged gastrointestinal injury. Health Phys. 109(5):440–451.
  • Kaul DC, Scott WH. 1984. Dose and cell survival calculations in anthropomorphic phantoms. In: Broerse JJ and MacVittie TJ, editors. Response of different species to total body irradiation. Dordrecht: Martinus Nijhoff Publishers. p. 29–42.
  • Kiang JG, Jiao W, Cary LH, Mog SR, Elliott TB, Pellmar TC, Ledney GD. 2010. Wound trauma increases radiation-induced mortality by activation of iNOS pathway and elevation of cytokine concentrations and bacterial infection. Radiat Res. 173(3):319–332.
  • Kiang JG, Ledney GD. 2013. Skin injuries reduce survival and modulate corticosterone, C-reactive protein, complement component 3, IgM, and prostaglandin E 2 after whole-body reactor-produced mixed field (n + gamma-photons) irradiation. Oxid Med Cell Longev. 2013:821541.
  • Kiang JG, Zhai M, Liao PJ, Bolduc DL, Elliott TB, Gorbunov NV. 2014. Pegylated G-CSF inhibits blood cell depletion, increases platelets, blocks splenomegaly, and improves survival after whole-body ionizing irradiation but not after irradiation combined with burn. Oxid Med Cell Longev. 2014:481392.
  • Kiang JG, Zhai M, Liao PJ, Ho C, Gorbunov NV, Elliott TB. 2017. Thrombopoietin receptor agonist mitigates hematopoietic radiation syndrome and improves survival after whole-body ionizing irradiation followed by wound trauma. Mediators Inflamm. 2017:7582079.
  • Kiang JG, Zhai M, Bolduc DL, Smith JT, Anderson MN, Ho C, Lin B, Jiang S. 2017. Combined therapy of pegylated G-CSF and alxn4100TPO improves survival and mitigates acute radiation syndrome after whole-body ionizing irradiation alone and followed by wound trauma. Radiat Res. 188(5):476–490.
  • Knudson GB, Ainsworth EJ, Eng RR, Fry RM, Kearsley E, Multon ÉT, McClain DE. 2002. Nuclear/biological/chemical combined injury effects: expert panel consensus. Mil. Med. 167(suppl_1):113–115.
  • Kramer K, Li A, Madrigal J, Sanchez B, Millage K. 2016. Monte Carlo modeling of the initial radiation emitted by an improvised nuclear device in the national capital region, revision 1. Report No. DTRA-TR-13–045 (R1) Fort Belvoir, VA: Defense Threat Reduction Agency, Department of Defense.
  • Kramer K, Dant T, Li A, Millage K. 2017. Publicly released prompt radiation spectra suitable for nuclear detonation simulations, revision 1. Report No. DTRA-17–026 (R1) Fort Belvoir, VA: Defense Threat Reduction Agency, Department of Defense.
  • Kumar P, Wang P, Farese A, MacVittie TM, Kane MA. 2021. Metabolomics of multiorgan radiation injury in a non-human primate model with minimal bone marrow sparing reveals system-wide metabolic perturbations. Health Phys. 121(4):395–405.
  • Lenarczyk M, Lam V, Jensen E, Fish BL, Su J, Koprowski S, Komorowski RA, Harmann L, Migrino RQ, Li XA, et al. 2013. Cardiac injury after 10 Gy total body irradiation: indirect role of effects on abdominal organs. Radiat Res. 180(3):247–258.
  • MacVittie TJ, Monroy R, Vigneulle RM, Zeman GH, Jackson WE. 1991. The relative biological effectiveness of mixed fission-neutron-gamma radiation on the hematopoietic syndrome in the canine: effect of therapy on survival. Radiat Res. 128(1):S29–S36.
  • MacVittie TJ, Weiss JF, Browne D. Eds. 1995. Advances in the treatment of radiation injuries. Proceedings of the 2nd Consensus development conference on the treatment of radiation injuries, held in Bethesda, Maryland, USA, on 14–17 April 1995: Advances in the Biosciences Volume 94. Published by Pergamon/Elsevier Sciences, Inc, Tarrytown, NY (1996).
  • MacVittie TJ, Farese AM, Jackson WIII. 2005. Defining the full therapeutic potential of recombinant growth factors in the post radiation-accident environment: the effect of supportive care plus administration of G-CSF. Health Phys. 89:546–555.
  • MacVittie TJ, Bennett A, Booth C, Garofalo M, Tudor G, Ward A, Shea-Donohue T, Gelfond D, McFarland E, Jackson W, et al. 2012. The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation. Health Phys. 103(4):427–453.
  • MacVittie TJ, Bennett AW, Cohen V, Farese AM, Higgins A, Hankey KG. 2014. Immune cell reconstitution after exposure to potentially lethal doses of radiation in the nonhuman primate. Health Phys. 106(1):84–96.
  • MacVittie TJ, Farese AM, Jackson W. 2015. The hematopoietic syndrome of the acute radiation syndrome in rhesus macaques: a systematic review of the lethal dose response relationship. Health Phys. 109(5):342–366.
  • MacVittie TJ, Gibbs A, Farese AM, Barrow K, Bennett A, Taylor-Howell C, Kazi A, Prado K, Parker G, Jackson W. 2017. AEOL 10150 mitigates radiation-induced lung injury in the nonhuman primate: morbidity and mortality are administration schedule-dependent. Radiat Res. 187(3):298–318.
  • MacVittie TJ, Farese AM, Parker GA, Jackson WIII, Booth C, Tudor GL, Hankey KG, Potten C. 2019. The gastrointestinal syndrome of the acute radiation syndrome in rhesus macaques: a systematic review of the lethal dose response relationship with and without medical management. Health Phys. 116(3):305–338.
  • MacVittie TJ, Farese AM, Kane MA. 2019. ARS, DEARE, and multiple-organ injury: a strategic and tactical approach to link radiation effects, animal models, medical countermeasures, and biomarker development to predict clinical outcome, Commentary. Health Phys. 116(3):297–304.
  • MacVittie TJ, Farese AM, Parker GA, Jackson W. 2019. The time course of radiation-induced lung injury in a nonhuman primate model of partial-body irradiation with minimal bone marrow-sparing: clinical and radiographic evidence and the effect of Neupogen administration. Health Phys. 116(3):366–382.
  • MacVittie TJ, Jackson W. 2020. Acute radiation-induced GI-ARS and H-ARS in a canine model of mixed neutron/gamma relative to reference Co-60 gamma radiation: a retrospective study. Health Phys. 119(3):351–357.
  • MacVittie TJ, Farese AM, Parker GA, Bennett AW, Jackson WI. 2020. Acute radiation-induced lung injury in the nonhuman primate: a review and comparison of mortality and co-morbidities using models of partial-body irradiation with marginal bone marrow sparing and whole thorax lung irradiation. Health Phys. 119(5):559–587.
  • MacVittie TJ, Farese AM. 2020. Commentary: defining the concomitant and delayed multiple organ injury within the ARS and DEARE in the nonhuman primate model. Health Phys. 119(5):519–526.
  • MacVittie TJ, Farese AM, Jackson, WA, III. 2020. A systematic review of the hematopoietic acute radiation syndrome (H-ARS) in canines and non-human primates: acute mixed neutron/gamma vs. reference quality radiations. Health Phys. 119(5):527–558.
  • MacVittie TJ, Farese AM. 2021. Recent advances in medical countermeasure development against acute radiation exposure based on the US FDA animal rule. Special issue concerning medical management after high-dose radiation exposures. J Radiol Prot. 41(4):S438–S453.
  • Mahmud N, Devine SM, Weller KP, Parmar S, Sturgeon C, Nelson MC, Hewett T, Hoffman R. 2001. The relative quiescence of hematopoietic stem cells in nonhuman primates. Blood. 97(10):3061–3068.
  • Meineke V, Fliedner TM. 2005. Radiation-induced multi-organ involvement and failure: challenges for radiation accident medical management and future research. Br J Radiol. 27(Suppl):196–200.
  • Medhora M, Gao F, Fish BL, Jacobs ER, Moulder JE, Szabo A. 2012. Dose-modifying factor for captopril for mitigation of radiation injury to normal lung. J Radiat Res. 53(4):633–640.
  • Medhora M, Gao F, Gasperetti T, Narayanan J, Khan AH, Jacobs ER, Fish BL. 2019. Delayed Effects of Acute Radiation Exposure (DEARE) in juvenile and old rats: mitigation by lisinopril. Health Phys. 116:529–545.
  • Medhora M, Gasperetti T, Schamerhorn A, Gao F, Narayanan J, Lazarova Z, Jacobs ER, Tarima S, Fish BL. 2020. Wound trauma exacerbates acute, but not delayed, effects of radiation in rats: mitigation by Lisinopril. Int J Mol Sci. 21(11):3908.
  • Miller SJ, Chittajallu S, Sampson C, Fisher A, Unthank JL, Orschell CM. 2020. A potential role for excess tissue iron in development of cardiovascular delayed effects of acute radiation exposure. Health Phys. 119(5):659–665.
  • Monroy RL, MacVittie TJ, Darden JH, Schwartz GN, Patchen ML. 1986. The rhesus monkey: a primate model for hemopoietic stem cell studies. Exp Hematol. 14(10):904–911.
  • Moulder JE, Fish BL. 1989. Late toxicity of total body irradiation with bone marrow transplantation in a rat model. Int J Radiat Oncol Biol Phys. 16(6):1501–1509.
  • Moulder JE, Cohen EP. 2005. Radiation-induced multi-organ involvement and failure: the contribution of radiation effects on the renal system. Br J Radiol. 78(1):82–88.
  • Moulder JE, Cohen EP, Fish BL. 2011. Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation. Radiat Res. 175(1):29–36.
  • NIAID, RCNP/FDA, CDER CDRH/BARDA. 2022. GI-ARS Workshop: gastrointestinal acute radiation syndrome (GI-ARS) workshop mechanisms, models, markers, and medical countermeasures. NIAID 6701 Rockledge Drive, Bethesda, MD. p. 20817. August 29–30.
  • Parker GA, Cohen EP, Li N, Takayama K, Farese AM, MacVittie TJ. 2019. Radiation nephropathy in a nonhuman primate model of partial-body irradiation with minimal bone marrow sparing. Part 2: histopathology, mediators, and mechanisms. Health Phys. 116(3):409–425.
  • Parker GA, Li N, Takayama K, Booth C, Tudor GL, Farese AM, MacVittie TJ. 2019. Histological features of the development of intestine and mesenteric lymph node injury in a nonhuman primate model of partial-body irradiation with minimal bone marrow sparing. Health Phys. 116(3):426–446.
  • Parker GA, Li N, Takayama K, Farese AM, MacVittie TJ. 2019. Lung and heart injury in a nonhuman primate model of partial-body irradiation with minimal bone marrow sparing: histopathological evidence of lung and heart injury. Health Phys. 116(3):383–400.
  • Parker GA. 2022. Histopathology Atlas of acute radiation syndrome and delayed effects in rhesus macaques: kidney, lung, heart, intestine, and mesenteric lymph node, Parker GA, editor. San Diego, CA: Academic Press (Elsevier).
  • Peter RU. 2002. Management of skin injuries in radiation accidents: the cutaneous radiation syndrome. In: Ricks RC, Berger ME, O’Hara FM Jr., editors, The medical basis for radiation accident preparedness: the clinical care of victims. New York: The Parthenon Publishing Group. p. 225–229.
  • Prado C, Kazi A, Bennett A, MacVittie T, Prado K. 2015. Mean organ doses resulting from non-human primate whole thorax lung irradiation prescribed to mid-line tissue. Health Phys. 109(5):367–373.
  • Patterson AM, Plett AP, Chua H-L, Sampson CH, Fisher A, Feng H, Unthank 1, Miller JL, Katz SJ, MacVittie BP, et al. 2020. Development of a model of the acute and delayed effects of high dose radiation exposure in jackson diversity outbred mice; comparison to inbred c57bl/6 mice. Health Phys. 119(5):633–646.
  • Plett PA, Sampson CH, Chua HL, Joshi M, Booth C, Gough A, Johnson CS, Katz BP, Farese AM, Parker J, et al. 2012. Establishing a murine model of the hematopoietic syndrome of the acute radiation syndrome. Health Phys. 103(4):343–355.
  • Plett PA, Sampson CH, Chua HL, Jackson W, Vemula S, Sellamuthu R, Fisher A, Feng H, Wu T, MacVittie TJ, et al. 2015. The H-ARS dose response relationship (DRR): validation and variables. Health Phys. 109(5):391–398.
  • Prado C, MacVittie TJ, Bennett AW, Kazi A, Farese AM, Prado K. 2017. Organ doses associated with partial-body irradiation with 2.5% bone marrow sparing of the non-human primate: a retrospective study. Radiat Res. 188(6):615–625.
  • Prins R, Browning T, Dant T, Cook J, Millage K. 2019. Estimated of urban NUDET organ neutron dose in a survivable zone. Report No. DTRA-TR-19–008. Fort Belvoir, VA: Defense Threat Reduction Agency, Department of Defense.
  • Radtke S, Adair JE, Giese MA, Chan YY, Norgaard ZK, Enstrom M, Haworth KG, Schefter LE, Kiem HP. 2017. A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates. Sci Transl Med. 9(414):eaan1145.
  • Reeves GI. 2012. Biophysics and medical effects of enhanced radiation weapons. Health Phys. 103(2):150–158.
  • Rios CI, Hollingsworth BA, DiCarlo AL, Esker JE, Satyamitra MM, Silverman TA, Winters TA, Taliaferro LP. 2022. Animal care in radiation medical countermeasure studies. Radiat Res. 198(5):514–535.
  • Sawyer L. 2010. Where are the countermeasures? Protecting America’s health from CBRN threats: a report of the National Biodefense Science Board. Biosecur Bioterror. 8(2):203–207.
  • Schimpff SC. 1990. Infections in radiation accidents. In: Browne D, Weiss JF, MacVittie TJ, Pillai MV, editrors. Treatment of radiation injuries. New York: Plenum Press; p. 75–85.
  • Sharma NK, Holmes-Hampton GP, Kumar VP, Biswas S, Wuddie K, Stone S, Aschenake Z, Wilkins WL, Fam CM, Cox GN, et al. 2020. Delayed effects of acute whole body lethal radiation exposure in mice pre-treated with BBT-059. Sci Rep. 10:6825.
  • Shea-Donohue T, Fasano A, Zhao A, Notari L, Yan S, Sun R, Bohl JA, Desai N, Tudor G, Morimoto M, et al. 2016. Mechanisms involved in the development of the chronic gastrointestinal syndrome in nonhuman primates after total-body irradiation with bone marrow shielding. Radiat Res. 185(6):591–603.
  • Simpson RE, Tochilin E, Goldstein N. 1963. Neutron and gamma-ray dosimetry in an animal exposure volume at a pulsed TRIGA REACTOR. Health Phys. 9:1021–1030.
  • Singh VK, Romaine PL, Seed TM. 2015. Medical countermeasures for radiation exposure and related injuries: characterization of medicines, FDA-approval status and inclusion into the strategic national stockpile. Health Phys. 108(6):607–630.
  • Singh VJ, Garcia M, Seed TM. 2017. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status. Int J Radiat Biol. 93(9):870–884.
  • Singh VJ, Seed TM. 2017. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. Int J Radiat Biol. 93(9):851–869.
  • Singh VK, Seed TM. 2020. Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems. Expert Opin Pharmacother. 21(3):317–337.
  • Singh VK, Seed TM. 2021. Repurposing pharmaceuticals previously approved by regulatory agencies to medically counter injuries arising either early or late following radiation exposure. Front Pharmacol. 12:624844.
  • Sorensen DK, Bond VP, Cronkite EP, Perman V. 1960. An effective therapeutic regimen for the hemopoietic phase of the actue radiation syndrome in dogs. Radiat Res. 13(5):669–685.
  • Stanley RE, Seigneur LJ, Strike TA. 1966. The acute mortality response of monkeys (Macaca mulatta) to mixed gamma-neutron radiations and 250 kVp x rays. Bethesda, MD: Armed Forces Radiobiology Research Institute; AFRRI SP66-2.
  • Stricklin D, Kramer K, Crary D, Prins R. 2018. Review of deterministic neutron RBEs for survivable personnel radiation exposures from nuclear detonation simulation. Report No. DTRA-TR-19–001. Fort Belvoir, VA: Defense Threat Reduction Agency, Department of Defense.
  • Stricklin DL, VanHorne-Sealy J, Rios Ci S, Carnell LA, Taliaferro LP. 2021. Neutron radiobiology and dosimetry. report: inter-agency neutron radiobiology and dosimetry workshop, Rockville MD. Radiat Res. 195(5):480–496.
  • Takatoku M, Sellers S, Agricola BA, Metzger ME, Kato I, Donahue RE, Dunbar CE. 2001. Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J Clin Invest. 108(3):447–455.
  • Thrall KD, Love R, OʼDonnell KC, Farese AM, Manning R, MacVittie TJ. 2015. An interlaboratory validation of the radiation dose response relationship (DRR) for the H-ARS in the rhesus macaque. Health Phys. 109(5):502–510.
  • Thrall KD, Mahendra S, Jackson MK, Jackson WI, Farese AM, MacVittie TJ. 2019. A comparative dose response relationship (DRR) between genders for mortality and morbidity of radiation-induced lung injury in rhesus macaque. Health Phys. 116(3):354–365.
  • Timmer-Bonte JN, de Boo TM, Smit HJ, Biesma B, Wilschut FA, Cheragwandi SA, Termeer A, Hensing CA, Akkermans J, Adang EM, et al. 2005. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch randomized phase III study. J Clin Oncol. 23(31):7974–7984.
  • Tsukamoto T, Antonic V, El Hajj I, Stojadinovic A, Binion DG, Izadjoo MJ, Yokota H, Pape HC, Bauer AJ. 2011. Novel model of peripheral tissue trauma-induced inflammation and gastrointestinal dysmotility. Neurogastroenterol Motil. 23(4):379–386, e164.
  • Turbyfill CL, Pitchford TL, Cramer MB. 1968. Monkey (macaca mulatta) survival time after pulsed gamma-neutron irradiation. Armed Forces Radiobiology Research Institute (AFRRI), Bethesda, MD, USA, SR68-5.
  • Unthank J, Miller SJ, Quickery AK, Ferguson EL, Wang M, Sampson CH, Chua HL, DiStasi MR, Feng H, Fisher A, et al. 2015. Delayed effects of acute radiation exposure in a murine model of the H-ARS: multiple-organ injury consequent to <10Gy total-body irradiation. Health Phys. 109:511–521.
  • Unthank JL, Ortiz M, Trivedi H, Pelus LM, Sampson CH, Sellamuthu R, Fisher A, Chua HL, Plett A, Orschell CM, et al. 2019. Cardiac and renal delayed effects of acute radiation exposure: organ differences in vasculopathy, inflammation, senescence and oxidative balance. Radiat Res. 191(5):383–397.
  • US Food and Drug Administration. 2015. Guidance for industry: product development under the Animal Rule. Washington, DC: US Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CEBR). www.fda.gov/ downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm399217.pdf
  • van Bekkum DW. 1991. Radiation sensitivity of the hemopoietic stem cell. Radiat Res. 128(1 Suppl):S4–S8.
  • van Luijk P, Novakova-Jiresova A, Faber H, Schippers JM, Kampinga HH, Meertens H, Coppes RP. 2005. Radiation damage to the heart enhances early radiation-induced lung function loss. Cancer Res. 65(15):6509–6511.
  • Van Dam D, De Deyn PP. 2006. Drug discovery in Dimentia: the role of rodent models. Nat Rev Drug Discov. 5(11):956–970.
  • van der Staay FJ. 2006. Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy. Brain Res Rev. 52(1):131–159.
  • Varga OE, Hansen AK, Sandoe P, Olsson AS. 2010. Validating animal models for preclinical research: a scientific and ethical discussion. Altern Lab Anim. 38(3):245–248.
  • Vigneulle RM, Rao S, Fasano A, MacVittie TJ. 2002. Structural and functional alterations of the gastrointestinal tract following radiation-induced injury in the rhesus monkey. Dig Dis Sci. 47(7):1480–1491.
  • Wang J, Wang B, Chen D, Luo Y. 1991. The response of dogs to mixed neutron-gamma radiation with different n/g ratios. Radiat Res. 128(1):S42–S46.
  • Wang J, Shao L, Hendrickson HP, Liu L, Chang J, Luo Y, Seng J, Pouliot M, Authier S, Zhou D, et al. 2015. Total-body irradiation in the hematopoietic dose range induces substantial intestinal injury in nonhuman primates. Radiat Res. 184(5):545–553.
  • Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, et al. 2004. Medical management of the acute radiation syndrome: recommendations of the strategic national stockpile radiation working group. Ann Intern Med. 140(12):1037–1051.
  • Wiernik G. 1966a. Changes in the villous pattern of the human jejunum associated with heavy radiation damage. Gut. 7(2):149–153.
  • Wiernik G. 1966b. In-vivo cell kinetics of a normal human tissue. Br Med J. 2(5510):385–387.
  • Wiernik G. 1966c. Radiation damage and repair in the human jejunal mucosa. J Pathol Bacteriol. 91(2):389–393.
  • Wilson SG. Jr. 1959. Radiation-induced gastrointestinal death in the monkey. Am J Pathol. 35(6):1233–1251.
  • Willner P. 1991. Behavioural models in psychopharmacology. In: P. Willner, ed. Behavioural models in psychopharmacology: theoretical, industrial, and clinical perspectives. New York: Cambridge University Press; p. 3–18.
  • Wingate CL, Page NP, Ainsworth EJ. 1967. Comparison of dose patterns in a dog exposed to neutrons and x rays. Radiat Res. 32(3):404–416.
  • Wise D, Turbyfill CL. 1968. The acute mortality response of monkeys (Macaca mulatta) to pulsed mixed gamma-neutron radiation. Bethesda, MD: Armed Forces Radiobiology Research Institute (AFRRI), SR68-17.
  • Wong K, Chang PY, Fielden M, Downey A-M, Bunin D, Bakke J, Gahagen J, Iyer L, Doshi S, Wierzbicki S, et al. 2020. Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates. Int J Radiat Biol. 96(1):155–166.
  • Yu J-Z, Lindeblad M, Lyubimov A, Neri F, Smith B, Szilagyi E, Halliday L, MacVittie T, Nanda J, Bartholomew A. 2015. Subject-based versus population-based care after radiation exposure. Radiat Res. 184(1):46–55.
  • Zalesak-Kravec S, Huang W, Wang PX, Yu J, Liu T, Defnet AE, Moise AR, Farese AM, MacVittie TM, Kane MA. 2021. Multi-omic analysis of nonhuman primate heart after partial-body radiation with minimal bone marrow sparing. Health Phys. 121(4):352–371.
  • Zellmer RW and Pickering JE. 1960. Biological effects of nuclear radiation in primates. Proj Rep USAF Sch Aviat Med. 60(66):1–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.